Application no. and date | 10706539.3 (espacenet) (Federated) (European Patent Register), 20100226 | Patent/reg. no. and date | DK/EP 2401272, 20170111 | Publication date | 20120104 | Priority no. and date | EP 09153964, 20090227 | EP pub. no. and date |
EP 2401272 20120104 | Effective date | | Applicant/owner | Janssen Pharmaceuticals, Inc., 1125 Trenton-Harbourton Road
Titusville, NJ 08560, US | Applicant ref. no. | Janssen TIP200EPPCT | Inventor | DE KOCK, Herman, Wolfseind 10
B-2370 Arendonk, BE, VAN REMOORTERE, Peter, Jozef, Maria, 44 Western Way
NJ 08540 Princeton, US, VANDECRUYS, Roger, Petrus, Gerebern, Langstraat 108
B-2260 Westerlo, BE | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 31/47 (2006.01) , A61K 31/4725 (2006.01) , A61K 9/14 (2006.01) , A61P 31/14 (2006.01) , C07D 417/04 (2006.01) | Title | AMORF SALT AF EN MAKROCYKLISK INHIBITOR AF HCV | Int. application no. | EP2010001197 | Int. publication no. | WO2010097229 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|